334708-05-3

Basic information

• Product Name: 2-Hydroxy-5-sulfopyridine-3-carboxylic acid
• Synonyms: 2-Hydroxy-5-sulfopyridine-3-carboxylic acid
• CAS NO: 334708-05-3
• Molecular Formula: C6H5NO6S
• Molecular Weight: 219.17
• Mol File: 334708-05-3.mol
• Article Data: 7

Chemical Properties

• Melting Point: 273°
• Appearance: /
• CAS DataBase Reference: 2-Hydroxy-5-sulfopyridine-3-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Hydroxy-5-sulfopyridine-3-carboxylic acid(334708-05-3)
• EPA Substance Registry System: 2-Hydroxy-5-sulfopyridine-3-carboxylic acid(334708-05-3)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 334708-05-3(Hazardous Substances Data)

Usage

General Description

2-Hydroxy-5-sulfopyridine-3-carboxylic acid, also known as 5-Sulfopyridine-2-carboxy-3-hydroxypyridine, is a chemical compound with the molecular formula C6H5NO7S. It is a derivative of pyridine and contains a hydroxyl group and a sulfonic acid group. 2-Hydroxy-5-sulfopyridine-3-carboxylic acid is often used in the production of pharmaceuticals, agrochemicals, and organic synthesis. It has various applications, including as a building block in the synthesis of complex molecules and as a chelating agent in metal coordination. Additionally, 2-Hydroxy-5-sulfopyridine-3-carboxylic acid has potential industrial uses in the production of dyes, pigments, and corrosion inhibitors.

Upstream product

• 609-71-2 2-hydroxy-3-carboxypyridine 

Downstream Products

• 4027-59-2 3-Ethyl-1H-pyrazole-5-carboxylic Acid 
• 247582-73-6 2-Ethoxy-5-(4-ethylpiperazin-1-ylsulphonyl)pyridine-3-carboxylic Acid 

Relevant articles and documents

Therapeutic agents

The invention relates anhydrous para-toluenesulphonic acid salts of 3-ethyl-5-[5-(4-ethylpiperazin-1-ylsulphonyl)-2-(2-methoxyethoxy) pyridin-3-yl]-2-(pyridin-2-yl)methyl-2,6-dihydro-7H-pyrazolo [4,3-d]pyrimidin-7-one having the formula (I): a process for

Novel process for the preparation of pyrazolopyrimidinones

There is provided a process for the production a compound of general formula I: 1wherein A, R1, R2, R3 and R4 have meanings given in the description, which process comprises the dehydrogenation of a compound of general formula II, 2

Pyrazolopyrimidine derivatives

The present invention provides a compound of formula (I): where Q is a group of formula: These compounds inhibit cyclic guanosine 3',5'-monophosphate phosphodiesterases (cGMP PDEs). More notably, the compounds are potent and selective inhibitors of the type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases and have utility therefore in a variety of therapeutic areas. In particular, the present compounds are of value for the curative or prophylactic treatment of mammalian sexual disorders.